Form D · Biotechnology

Kadmon Holdings, LLC

New York, NY · CIK 0001557142

Offering snapshot reported Jul 31, 2014 · SEC filing

Reported sold
$5.69M
Offering amount: $50M
Investors reported
3
Form D · investor count
Minimum accepted
$500K
Reported outside-investor minimum
First sale
Jul 25, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 31, 2014Initial$5,690,000No comparison3SEC filing
Aug 30, 2012Initial$4,744,220No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$3M
Finders' fees
$0
Form D file number
021-222099

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Jefferies LLC2347
Piper Jaffray & Co665

Source: Form D, filed Jul 31, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eugene Bauer Director
David Blaustein Director
Dixon Boardman Director
Andrew Cohen Director
Alexandria Forbes Director
Steven N Gordon Executive
Financial John Thomas Promoter
Richard Mulligan Director, Executive
John Ryan Executive
Adriann Sax Executive
Thomas Shenk Director
Harlan Waksal Director
Samuel D Waksal Director, Executive
Larry Witte Executive
Susan Wiviott Director
Louis Shengda Zan Director
Zhenping Zhu Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
450 East 29 Th Street
New York, NY, 10016